Literature DB >> 25323546

Antimicrobial usage among hospitalized children in Latvia: a neonatal and pediatric antimicrobial point prevalence survey.

Inese Sviestina1, Dzintars Mozgis2.   

Abstract

BACKGROUND AND
OBJECTIVE: The point prevalence survey was conducted as part of the Antibiotic Resistance and Prescribing in European Children (ARPEC) Project. The study aimed at analyzing pediatric and neonatal antimicrobial prescribing patterns in Latvian hospitals, to identify targets for quality improvement.
MATERIALS AND METHODS: A one day cross-sectional point prevalence survey on antibiotic use in hospitalized children was conducted in November 2012 in 10 Latvian hospitals, using a previously validated and standardized method. The survey included all inpatient pediatric and neonatal beds and identified all children receiving an antimicrobial treatment on the day of survey.
RESULTS: Overall 549 patients were included in the study; 167 (39%) patients admitted to pediatric wards and 25 (21%) patients admitted to neonatal wards received at least one antimicrobial. Pediatric top three antibiotic groups were third-generation cephalosporins (55 prescriptions, 28%), extended spectrum penicillins (n=32, 16%) and first-generation cephalosporins (n=26, 13%). Eleven pediatric patients (85%) received surgical prophylaxis more than 1 day; 143 pediatric patients (86%) received antibiotics intravenously. Lower respiratory tract infections were the most common indications for antibiotic use both in pediatric (n=60, 35.9%) and neonatal patients (n=9, 36%). The most used antibiotics for neonatal patients were benzylpenicillin (n=12, 32%), and gentamicin (n=9, 24%).
CONCLUSIONS: We identified a few problematic areas, which need improvement: the high use of third-generation cephalosporins for pediatric patients, prolonged surgical prophylaxis, predominant use of parenteral antibiotics and an urgent need for local antibiotic guidelines.
Copyright © 2014 Lithuanian University of Health Sciences. Production and hosting by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Hospitalized children; Parenteral antibiotics; Point prevalence survey; Third-generation cephalosporins

Mesh:

Substances:

Year:  2014        PMID: 25323546     DOI: 10.1016/j.medici.2014.08.005

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  5 in total

1.  Antibiotic usage in Chinese children: a point prevalence survey.

Authors:  Jiao-Sheng Zhang; Gang Liu; Wen-Shuang Zhang; Hai-Yan Shi; Gen Lu; Chang-An Zhao; Chang-Chong Li; Yan-Qi Li; Ya-Nan Shao; Dai-Yin Tian; Ming-Jie Ding; Chun-Yan Li; Li-Juan Luo; Xiao-Yan Dong; Ping Jin; Ping Wang; Chun-Mei Zhu; Chuan-Qing Wang; Yue-Jie Zheng; Ji-Kui Deng; Mike Sharland; Ying-Fen Hsia; Kun-Ling Shen; Yong-Hong Yang
Journal:  World J Pediatr       Date:  2018-07-30       Impact factor: 2.764

2.  Prescription of antibiotics in Riga and Vilnius tertiary children's hospitals.

Authors:  Inese Sviestina; Vytautas Usonis; Vilija Gurksniene; Sigita Burokiene; Inga Ivaskeviciene; Dzintars Mozgis
Journal:  Eur J Hosp Pharm       Date:  2017-03-22

3.  A study of antimicrobial use in children admitted to pediatric medicine ward of a tertiary care hospital.

Authors:  Sandip Baidya; Avijit Hazra; Supratim Datta; Amal Kanti Das
Journal:  Indian J Pharmacol       Date:  2017 Jan-Feb       Impact factor: 1.200

4.  Antimicrobial Utilization among Neonates and Children: A Multicenter Point Prevalence Study from Leading Children's Hospitals in Punjab, Pakistan.

Authors:  Zia Ul Mustafa; Amer Hayat Khan; Muhammad Salman; Syed Azhar Syed Sulaiman; Brian Godman
Journal:  Antibiotics (Basel)       Date:  2022-08-04

5.  Point Prevalence Surveys of Antimicrobial Use among Hospitalized Children in Six Hospitals in India in 2016.

Authors:  Sumanth Gandra; Sanjeev K Singh; Dasaratha R Jinka; Ravishankar Kanithi; Ashok K Chikkappa; Anita Sharma; Dhanya Dharmapalan; Anil Kumar Vasudevan; Onkaraiah Tunga; Akhila Akula; Garima Garg; Yingfen Hsia; Srinivas Murki; Gerardo Alvarez-Uria; Mike Sharland; Ramanan Laxminarayan
Journal:  Antibiotics (Basel)       Date:  2017-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.